Norwegian Cruise Line Holdings Announces Revisions to “SailSAFE Health and Safety Protocols”
Norwegian Cruise Line Holdings Ltd. today announced it will no longer require guests to complete pre-cruise COVID-19 testing unless required by local regulations.
This policy will go into effect across Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises beginning August 1, 2022.
The pre-embarkation testing requirement will remain in place for guests currently traveling on voyages departing from destinations with local testing regulations, including but not limited to the U.S., Canada, Greece and Bermuda.
The relaxation of the testing policy is in line with the rest of the travel, leisure and hospitality industry worldwide as society continues to adapt and return to a state of normalcy. The Company continues to strongly recommend all guests be up to date on vaccination protocols and test at their convenience prior to travel.
All voyages across the Company’s three brands continue to operate under its robust science-backed SailSAFE health and safety program which will evolve along with the public health environment. The Company also follows applicable local protocols at the ports and destinations it visits.